Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Lenvatinib
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Kisplyx 10mg capsules
0801050BVBCABAB
|
Kisplyx | Lenvatinib | Malignant Disease and Immunosuppression | No data available |
|
Kisplyx 4mg capsules
0801050BVBCAAAA
|
Kisplyx | Lenvatinib | Malignant Disease and Immunosuppression | No data available |
|
Lenvatinib 10mg capsules
0801050BVAAABAB
|
Lenvatinib | Lenvatinib | Malignant Disease and Immunosuppression | No data available |
|
Lenvatinib 4mg capsules
0801050BVAAAAAA
|
Lenvatinib | Lenvatinib | Malignant Disease and Immunosuppression | No data available |
|
Lenvima 10mg capsules
0801050BVBBABAB
|
Lenvima | Lenvatinib | Malignant Disease and Immunosuppression | No data available |
|
Lenvima 4mg capsules
0801050BVBBAAAA
|
Lenvima | Lenvatinib | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.